Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 1/20 | 0.49 |
| ▸ | PGR | P06401 | 7/20 | 0.44 |
| ▸ | PLK4 | O00444 | 7/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 5/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | FLT3 | P36888 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ALB | P02768 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14547228 | 0.87 | GSK3B (0.59) | GSK3BPGRPLK4AURKBCYP2C19 | |
| SCHEMBL14547263 | 0.84 | GSK3B (0.48) | GSK3BPGRPLK4AURKBCYP2C19 | |
| SCHEMBL14547133 | 0.84 | GSK3B (0.48) | GSK3BPGRPLK4AURKBCYP2C19 | |
| SCHEMBL14547146 | 0.83 | GSK3B (0.43) | GSK3BPGRPLK4AURKBCYP2C19 | |
| SCHEMBL14547229 | 0.83 | GSK3B (0.43) | GSK3BPGRPLK4AURKBCYP2C19 | |
| SCHEMBL5568413 | 0.82 | GSK3B (0.73) | GSK3BPGRPLK4AURKBCYP2C19 | |
| SCHEMBL14524566 | 0.81 | GSK3B (0.42) | GSK3BPGRPLK4AURKBCYP2C19 | |
| SCHEMBL14547144 | 0.81 | GSK3B (0.46) | GSK3BPGRPLK4AURKBCYP2C19 | |
| SCHEMBL14547269 | 0.81 | GSK3B (0.47) | GSK3BPGRPLK4AURKBCYP2C19 | |
| SCHEMBL14547305 | 0.80 | PLK4 (0.49) | GSK3BPLK4AURKBCYP2C19FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7205328-B2 | Aids viricide | IRM LLC (BM) | 2007-04-17 | — | — | US | disclosed |
| US-7205328-B2 | Aids viricide | IRM LLC (BM) | 2007-04-17 | — | — | US | disclosed |
| US-7205328-B2 | Aids viricide | IRM LLC (BM) | 2007-04-17 | — | — | US | disclosed |
| US-20040152755-A1 | Oxindoles with anti-HIV activity | IRM LLC, A DELAWARE LLC (BM) | 2004-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152755-A1 | Oxindoles with anti-HIV activity | IDO1, API5, NFATC1 | GSK3B 566/4885PGR 2979/4885PLK4 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.